Skip to content

A clinical trial evaluating the effectiveness of photobiomodulation devices in improving upper limb function in stroke patients

A Single-centered, Randomized, Double-blinded, Prospective, Pilot trial to evaluate Upper Motor Function Improvement of transcranial-Photobiomodulation device in Stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011891
Enrollment
26
Registered
2026-04-21
Start date
2025-03-11
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The investigational intervention is a home-use transcranial photobiomodulation (t-PBM) medical device intended for stroke rehabilitation. The device delivers near-infrared laser light
however, the device will emit only 1/50 of the energy delivered by the active treatment device. All participants will perform the intervention in a home setting, and study procedures—including duratio

Sponsors

Y&J Bio Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women aged 19 to 90 years 2. Individuals diagnosed with first-ever cerebral infarction or intracerebral hemorrhage 3. Individuals with an Fugl Meyer Assessment-Upper Extremity score of 58 or lower 4. Individuals who are fluent in Korean and have no impairment in reading, writing, or auditory comprehension 5. Individuals who have agreed to participate for the entire duration of the clinical trial

Exclusion criteria

Exclusion criteria: 1. Individuals with visual impairments 2. Individuals exhibiting signs of unilateral neglect 3. Individuals whose upper limb dysfunction may be caused by joint contracture or stiffness due to infection or trauma 4. Individuals with intracranial metallic objects (e.g., brain stimulators, neurostimulators, aneurysm clips, cochlear implants) 5. Individuals with uncontrolled cardiac, renal, or hepatic disease 6. Individuals deemed unsuitable for participation in the clinical trial by the investigator

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Upper Extremity Assessment;Safety

Secondary

MeasureTime frame
Action Research Arm Test;National Institutes of Health Stroke Scale;Modified Barthel Index

Countries

Korea, Republic of

Contacts

Public ContactHyelim Chun

St. Peter's Hospital

hyelimchun23@gmail.com+82-2-3307-0844

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: May 1, 2026